{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:33Z","timestamp":1787032773984,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,4]]},"DOI":"10.7759\/cureus.11911","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T02:26:44Z","timestamp":1607135204000},"source":"Crossref","is-referenced-by-count":5,"title":["Hemophagocytic Lymphohistiocytosis as a Manifestation of Underlying Visceral Leishmaniasis"],"prefix":"10.7759","author":[{"given":"Michael D","family":"Diamantidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Palioura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Tsangalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2007.05.001","article-title":"Hemophagocytic syndromes","volume":"21","author":"Janka GE","year":"2007","unstructured":"Janka GE. Hemophagocytic syndromes. Blood Rev. 2007, 21:245-253. 10.1016\/j.blre.2007.05.001","journal-title":"Blood Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14147","article-title":"Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities","volume":"174","author":"Brisse E","year":"2016","unstructured":"Brisse E, Wouters CH, Matthys P. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities. Br J Haematol. 2016, 174:203-217. 10.1111\/bjh.14147","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2308-z","article-title":"Hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in systemic lupus erythematosus","volume":"106","author":"Souto Filho JD","year":"2017","unstructured":"Souto Filho JD, Lima PA, Paulo AB, Souza AS. Hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in systemic lupus erythematosus. Int J Hematol. 2017, 106:727-728. 10.1007\/s12185-017-2308-z","journal-title":"Int J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s1130-1406(07)70063-3","article-title":"Disseminated histoplasmosis with hemophagocytic syndrome in a patient with AIDS: description of one case and review of the Spanish literature","volume":"24","author":"Gil-Brusola A","year":"2007","unstructured":"Gil-Brusola A, Pem\u00e1n J, Santos M, Salavert M, Lacruz J, Gobernado M. Disseminated histoplasmosis with hemophagocytic syndrome in a patient with AIDS: description of one case and review of the Spanish literature. Rev Iberoam Micol. 2007, 24:312-316. 10.1016\/s1130-1406(07)70063-3","journal-title":"Rev Iberoam Micol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2008.11.010","article-title":"Reconstitution inflammatory syndrome related to histoplasmosis, with a hemophagocytic syndrome in HIV infection","volume":"58","author":"De Lavaissi\u00e8re M","year":"2009","unstructured":"De Lavaissi\u00e8re M, Manceron V, Bour\u00e9e P, et al.. Reconstitution inflammatory syndrome related to histoplasmosis, with a hemophagocytic syndrome in HIV infection. J Infect. 2009, 58:245-247. 10.1016\/j.jinf.2008.11.010","journal-title":"J Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-019-03877-7","article-title":"Daratumumab-associated hemophagocytic lymphohistiocytosis","volume":"99","author":"Woods A","year":"2020","unstructured":"Woods A, Wooten M, Thompson Heffner L, Waller E. Daratumumab-associated hemophagocytic lymphohistiocytosis. Ann Hematol. 2020, 99:181-182. 10.1007\/s00277-019-03877-7","journal-title":"Ann Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH- 2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH- 2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-131. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.605","article-title":"Hemophagocytic lymphohistiocytosis: pathogenesis and treatment","volume":"2013","author":"Janka GE","year":"2013","unstructured":"Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013, 2013:605-611. 10.1182\/asheducation-2013.1.605","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.08.004","article-title":"Hemophagocytic syndrome: primary forms and predisposing conditions","volume":"49","author":"Sepulveda FE","year":"2017","unstructured":"Sepulveda FE, de Saint Basile G. Hemophagocytic syndrome: primary forms and predisposing conditions. Curr Opin Immunol. 2017, 49:20-26. 10.1016\/j.coi.2017.08.004","journal-title":"Curr Opin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-814244","article-title":"Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis","volume":"132","author":"Chinn IK","year":"2018","unstructured":"Chinn IK, Eckstein OS, Peckham-Gregory EC, et al.. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood. 2018, 132:89-100. 10.1182\/blood-2017-11-814244","journal-title":"Blood"},{"key":"ref11","article-title":"Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review","volume":"16","author":"Cascio A","year":"2012","unstructured":"Cascio A, Pernice LM, Barberi G, et al.. Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review. Eur Rev Med Pharmacol Sci. 2012, 16:1324-1337.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-02888-9","article-title":"Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19","volume":"112","author":"Takami A","year":"2020","unstructured":"Takami A. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19. Int J Hematol. 2020, 112:122-124. 10.1007\/s12185-020-02888-9","journal-title":"Int J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30628-0","article-title":"COVID- 19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta P","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID- 19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020, 395:1033-1034. 10.1016\/s0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2008.02.013","article-title":"Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis--case report and systematic review","volume":"56","author":"Rajagopala S","year":"2008","unstructured":"Rajagopala S, Dutta U, Chandra KS, Bhatia P, Varma N, Kochhar R. Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis--case report and systematic review. J Infect. 2008, 56:381-388. 10.1016\/j.jinf.2008.02.013","journal-title":"J Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1367-0","article-title":"Hemophagocytic syndrome associated with visceral leishmaniasis in an immunocompetent adult-case report and review of the literature","volume":"91","author":"Koub\u00e2a M","year":"2012","unstructured":"Koub\u00e2a M, M\u00e2aloul I, Marrakchi C, et al.. Hemophagocytic syndrome associated with visceral leishmaniasis in an immunocompetent adult-case report and review of the literature. Ann Hematol. 2012, 91:1143-1145. 10.1007\/s00277-011-1367-0","journal-title":"Ann Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1896-9","article-title":"Visceral leishmaniasis clinically mimicking lymphoma","volume":"93","author":"Evers G","year":"2014","unstructured":"Evers G, Pohlen M, Berdel WE, et al.. Visceral leishmaniasis clinically mimicking lymphoma. Ann Hematol. 2014, 93:885-887. 10.1007\/s00277-013-1896-9","journal-title":"Ann Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1380-3","article-title":"Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors","volume":"91","author":"Park HS","year":"2012","unstructured":"Park HS, Kim DY, Lee JH, et al.. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors. Ann Hematol. 2012, 91:897-904. 10.1007\/s00277-011-1380-3","journal-title":"Ann Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-018-02572-z","article-title":"Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan","volume":"109","author":"Yanagisawa R","year":"2019","unstructured":"Yanagisawa R, Nakazawa Y. Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan. Int J Hematol. 2019, 109:206-213. 10.1007\/s12185-018-02572-z","journal-title":"Int J Hematol"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27400","article-title":"Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis","volume":"65","author":"Gurunathan A","year":"2018","unstructured":"Gurunathan A, Boucher AA. Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2018, 65:27400.","journal-title":"Pediatr Blood Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14144","article-title":"Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options","volume":"174","author":"Brisse E","year":"2016","unstructured":"Brisse E, Matthys P, Wouters CH. Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol. 2016, 174:175-187. 10.1111\/bjh.14144","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/47013-hemophagocytic-lymphohistiocytosis-as-a-manifestation-of-underlying-visceral-leishmaniasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:24:57Z","timestamp":1707488697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/47013-hemophagocytic-lymphohistiocytosis-as-a-manifestation-of-underlying-visceral-leishmaniasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.11911","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,4]]}}}